Study to Evaluate the Effect of Cetuximab on Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors
Public ClinicalTrials.gov record NCT00698841. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate the Relationship Between Cetuximab Therapy and Corrected QT (QTc) Interval Changes in Patients With Advanced Malignancies From Solid Tumors
Study identification
- NCT ID
- NCT00698841
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Interventions
- Cetuximab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2009
- Primary completion
- Jan 31, 2010
- Completion
- Jan 31, 2010
- Last update posted
- Dec 23, 2015
2009 – 2010
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Alabama Cancer Center | Muscle Shoals | Alabama | 35661 | — |
| Donald W. Hill, MD | Casa Grande | Arizona | 85222 | — |
| Compassionate Cancer Care Medical Group, Inc | Corona | California | 92879 | — |
| Compassionate Cancer Care Medical Group Inc | Fountain Valley | California | 92708 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| Desert Hospital Comprehensive Cancer Center | Palm Springs | California | 92262 | — |
| Compassionate Cancer Care Medical Group, Inc | Riverside | California | 92501 | — |
| American Institute Research | Whittier | California | 90603 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Baptist Cancer Institute | Jacksonville | Florida | 32207 | — |
| Ocala Oncology Center | Ocala | Florida | 34471 | — |
| Brinz, Burroff, Gurtler, & Russo | Metairie | Louisiana | 70006 | — |
| Cancer Specialists Of Oklahoma | Oklahoma City | Oklahoma | 73112 | — |
| Pharma Resource | East Providence | Rhode Island | 02915 | — |
| Austin Cancer Centers | Austin | Texas | 78759 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00698841, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 23, 2015 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00698841 live on ClinicalTrials.gov.